abstract |
A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein Wnt signal pathway inhibitor encapsulated within the liposome formulation has a concentration ranging from 0.07 mg/ml to 0.5 mg/ml. |